genOway Improves its Growth With Major Japanese Biopharmaceutical Companies

Lyon (France) -- genOway (ALTERNEXT-NYSE EURONEXT: ALGEN; ISIN: FR0004053510), the biotechnology company dedicated to the development of genetically modified animal models, today announces strong growth of its business with major Japanese biopharmaceutical companies. The three Japanese biopharmaceutical companies, now customers of genOway, rank among the top ten of the nation’s biopharmaceutical industry. The amount of [...]

Thermo Fisher Scientific Extends Linear Ion Trap and Triple Stage Quadrupole Mass Spectrometer Trade-In Program

SAN JOSE, Calif. -- Thermo Fisher Scientific Inc., the world leader in serving science, announces the extension of its LC-MS ion trap and triple stage quadrupole trade-in programs to include the trade-in of instruments from any vendor. Scientists are invited to participate in the Traps and Triples Trade-In Program by trading in ion trap or [...]

Cemtrex Sees Business Opportunities from EPA Ruling on Sulfur Dioxide

FARMINGDALE, N.Y. -- -- Cemtrex Inc. (OTC:CTEI.ob - News) is optimistic about business opportunities resulting from the recent Environmental Protection Agency's (EPA's) ruling that sets the one-hour SO2 health standard at 75 parts per billion (ppb), down from the current standard of 140 ppb, a level designed to protect against short-term exposures ranging from five [...]

Esco Announces NEW Generation of Best-Selling Labculture Class II Biological Safety Cabinets

Singapore -- Esco announces the release of NEW generation Labculture Class II Biological Safety Cabinets, the industry's most certified biosafety cabinet product line. New generation Labculture Class II Biological Safety Cabinets feature: All models standardized to lower height (1540mm or 60.6") Enhanced Sentinel Gold 4-line LCD graphical interface Improved User Interface, simplified Menu navigation New/simplified [...]

ABI Expands Distribution of Rapid Heparin Antibody Test With Fisher Healthcare

Akers Biosciences, Inc (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, today announces a major distribution agreement with Fisher HealthCare for ABI’s PIFA® Heparin/PF4 Rapid Assay (PIFA HPF4) and related products. Fisher HealthCare is one of the USA’s leading healthcare product channels. The addition of Fisher HealthCare’s resources will expose [...]

ExonHit Signs an Exclusive Agreement with Genmab for Novel Splice Variant Targets in Breast Cancer

PARIS -- -- Regulatory News -- “This pilot study clearly demonstrates the ability of ExonHit’s technology to identify novel target candidates for breast cancer treatment approaches.” ExonHit applied its genome-wide SpliceArray™ technology to develop a unique database in breast cancer Genmab retains exclusive rights on 10 novel splice events to fuel its antibody discovery activity [...]

Amalgamated Capital Co-Leads $25 Million Senior Debt Financing for PNC Equity Partners’ Acquisition of Wheaton Industries

NEW YORK -- -- Amalgamated Capital (AmalCap), a recently formed division of Amalgamated Bank, announced today it served as Co-Lead Arranger for a $25 million senior secured credit facility in support of the acquisition of Wheaton Industries Inc. (Wheaton) by PNC Equity Partners II, L.P. AmalCap provides cash flow-based senior debt financing to support investments [...]

Southern California Cell Company Partners With Northern California Life Science Research Technology Company

COSTA MESA, Calif. -- -- DV Biologics LLC announced today that it has executed an agreement with System Biosciences LLC for the development of human-derived disease-specific induced pluripotent stem cell (iPSC) lines. iPSCs are pluripotent cells which are developed from non-pluripotent cells that have undergone gene expression changes to render them pluripotent giving them the [...]

Pall and New Brunswick Announce Collaboration on New Single-Use Bioreactors

PORT WASHINGTON, N.Y.--New Brunswick Scientific, an Eppendorf Company (Edison, NJ, www.nbsc.com), and Pall Corporation (Port Washington, NY, www.pall.com) today announced a joint product development and marketing agreement to create and supply new disposable bioreactor systems. “This is an exciting step forward, as the new system will enable us to offer an even broader range of [...]

Chiral Technologies to Showcase Immobilized and Coated Chiral Columns at HPLC 2010

WEST CHESTER, Pa. -- Chiral Technologies Worldwide will showcase its portfolio of immobilized and coated chiral columns at HPLC 2010, the 35th International Symposium on High Performance Liquid Phase Separations and Related Techniques (June 19-24, Hynes Convention Center, Boston), Booth 615. Chiral Technologies’ expanded line of immobilized columns affords new selectivity and better stability than [...]

Access IBO on Knowledge Center